These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 21568657)
41. Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand? Reznik E; Smith AW; Taube S; Mann J; Yondorf MZ; Parashar B; Wernicke AG Am J Clin Oncol; 2018 Feb; 41(2):197-212. PubMed ID: 28906259 [TBL] [Abstract][Full Text] [Related]
42. Pediatric glioblastoma: a single institution experience. Nikitović M; Stanić D; Pekmezović T; Gazibara MS; Bokun J; Paripović L; Grujičić D; Sarić M; Mišković I Childs Nerv Syst; 2016 Jan; 32(1):97-103. PubMed ID: 26537911 [TBL] [Abstract][Full Text] [Related]
43. Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme. Swartz AM; Li QJ; Sampson JH Immunotherapy; 2014; 6(6):679-90. PubMed ID: 25186601 [TBL] [Abstract][Full Text] [Related]
45. Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma. Färkkilä M; Jääskeläinen J; Kallio M; Blomstedt G; Raininko R; Virkkunen P; Paetau A; Sarelin H; Mäntylä M Br J Cancer; 1994 Jul; 70(1):138-41. PubMed ID: 8018525 [TBL] [Abstract][Full Text] [Related]
46. Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival. dos Santos MA; Pignon JP; Blanchard P; Lefeuvre D; Levy A; Touat M; Louvel G; Dhermain F; Soria JC; Deutsch E; Le Teuff G J Neurooncol; 2015 Jun; 123(2):307-14. PubMed ID: 25975195 [TBL] [Abstract][Full Text] [Related]
47. Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature. Likar R; Koestenberger M; Stultschnig M; Nahler G Anticancer Res; 2019 Oct; 39(10):5797-5801. PubMed ID: 31570484 [TBL] [Abstract][Full Text] [Related]
48. [Glioblastoma incident studies from May 2006 to May 2007 in Angers and Nice, France]. Delion M; Moraru C; Almayrac F; Von Langsdorff D; Paquis P; Menei P Neurochirurgie; 2010 Dec; 56(6):499-502. PubMed ID: 20870254 [TBL] [Abstract][Full Text] [Related]
49. P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients. Yamada E; Ishikawa E; Miyazaki T; Miki S; Sugii N; Kohzuki H; Tsurubuchi T; Sakamoto N; Watanabe S; Matsuda M Neurooncol Adv; 2023; 5(1):vdad079. PubMed ID: 37484760 [TBL] [Abstract][Full Text] [Related]
50. Current status of immunotherapy and gene therapy for high-grade gliomas. Marsh JC; Goldfarb J; Shafman TD; Diaz AZ Cancer Control; 2013 Jan; 20(1):43-8. PubMed ID: 23302906 [TBL] [Abstract][Full Text] [Related]
51. Long-term survivor of relapsed MFH on the thigh treated with autologous formalin-fixed tumor vaccine (AFTV) combined with limb-sparing surgery and radiotherapy. Todoroki T; Kondo T; Sugahara S; Morishita Y; Mori K; Ohno T World J Surg Oncol; 2011 Aug; 9():96. PubMed ID: 21864347 [TBL] [Abstract][Full Text] [Related]
52. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. Maier-Hauff K; Rothe R; Scholz R; Gneveckow U; Wust P; Thiesen B; Feussner A; von Deimling A; Waldoefner N; Felix R; Jordan A J Neurooncol; 2007 Jan; 81(1):53-60. PubMed ID: 16773216 [TBL] [Abstract][Full Text] [Related]
53. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes. Rehman AA; Elmore KB; Mattei TA Neurosurg Focus; 2015 Mar; 38(3):E14. PubMed ID: 25727223 [TBL] [Abstract][Full Text] [Related]
54. HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. Ahmed N; Brawley V; Hegde M; Bielamowicz K; Kalra M; Landi D; Robertson C; Gray TL; Diouf O; Wakefield A; Ghazi A; Gerken C; Yi Z; Ashoori A; Wu MF; Liu H; Rooney C; Dotti G; Gee A; Su J; Kew Y; Baskin D; Zhang YJ; New P; Grilley B; Stojakovic M; Hicks J; Powell SZ; Brenner MK; Heslop HE; Grossman R; Wels WS; Gottschalk S JAMA Oncol; 2017 Aug; 3(8):1094-1101. PubMed ID: 28426845 [TBL] [Abstract][Full Text] [Related]
55. Controversies in the treatment of elderly patients with newly diagnosed glioblastoma. Holdhoff M; Chamberlain MC J Natl Compr Canc Netw; 2013 Sep; 11(9):1165-72; quiz 1173. PubMed ID: 24029128 [TBL] [Abstract][Full Text] [Related]
56. Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence? Olivier T; Migliorini D Rev Neurol (Paris); 2023 Jun; 179(5):502-505. PubMed ID: 37012085 [TBL] [Abstract][Full Text] [Related]
57. [Therapeutic vaccination for glioblastoma]. Dietrich PY; Dutoit V Med Sci (Paris); 2020 Apr; 36(4):319-322. PubMed ID: 32356704 [No Abstract] [Full Text] [Related]
58. Agenus’ brain cancer vaccine doubles survival rate in GBM patients. Riedmann EM Hum Vaccin Immunother; 2014; 10(8):2139-40. PubMed ID: 25424916 [TBL] [Abstract][Full Text] [Related]
59. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Kristiansen K; Hagen S; Kollevold T; Torvik A; Holme I; Nesbakken R; Hatlevoll R; Lindgren M; Brun A; Lindgren S; Notter G; Andersen AP; Elgen K Cancer; 1981 Feb; 47(4):649-52. PubMed ID: 6164465 [TBL] [Abstract][Full Text] [Related]
60. Fractionated Radiation for Newly Diagnosed Supratentorial Glioblastoma Multiforme: In Regard to Brachman et al. Brown M; Bernhard E; Mitchel J; Stone H Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):210-211. PubMed ID: 26700716 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]